MedTrace Logo

Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study

NCT00384982 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2010-01-22

No results posted yet for this study

Summary

The MYocardial STem cell Administration after acute myocardial infaRction (MYSTAR) study is a multicenter, prospective, randomized, single-blind clinical trial designed to compare the early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of bone marrow-derived stem cells to patients after acute myocardial infarction with reopened infarct-related artery.

Conditions

Interventions

PROCEDURE

Bone marrow-derived stem cells implantation

percutaneous BM-derived cell therapy

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Irene Lang, MD · Department of Cardiology, Medical University of Vienna

  • Dietmar Glogar, MD · Department of Cardiology, Medical University of Vienna

  • Mariann Gyongyosi, MD · Department of Cardiology, Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00384982 on ClinicalTrials.gov